allcancercure.com

Experts are warning policy makers that allergic disease might replace infectious disease as a major cause of ill health in cities undergoing rapid demographic changes in developing countries.
New research tracking the number of cases of childhood eczema across the globe has revealed big changes in the prevalence of the condition over the last five to [...]

The Columbia Center for Children’s Environmental Health (CCCEH) at Columbia University’s Mailman School of Public Health, has received a $10.4 million grant from the National Institute of Environmental Health Sciences (NIEHS) to study environmental contributors to childhood asthma. The grant was awarded via a new NIEHS initiative called Disease Investigation through Specialized Clinically-Oriented Ventures in [...]

Over the course of the 20th Century, doctors waged war against infectious bacterial illness with the best new weapon they had: antibiotics.
But the emergence of dangerous, multi-drug resistant strains of tuberculosis and other killer infections means that in the 21st century antibiotics are losing ground against bacterial disease.
Now, researchers from Weill Cornell Medical College in [...]

Idiopathic pulmonary fibrosis is a disease with unknown cause with a very severe prognosis; when detected, it is already in an advanced stage. Patients suffering from it cannot develop with normality pulmonary gas exchange, and have a very reduced quality of life. Because of lack of an effective treatment, they rarely survive 5 years after [...]

A Dec. 12 Wall Street Journal opinion piece written by Merrill Matthews, executive director of the Council for Affordable Health Insurance, highlights the “tragedy of state governments forbidding citizens from exercising the basic right to buy health insurance from other states,” John Graham, director of health care studies at the Pacific Research Institute, writes in [...]

The convergence of socioeconomic and technology factors - the growing emphasis on drug self-administration for chronic conditions, the expected acceleration in protein- and peptide-based therapeutics, the availability of innovative inhaler device designs - is driving interest in pulmonary drug delivery technology and devices as an alternative to oral and parenteral routes of administration.
A number of [...]

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced the presentation of results from its Phase I trial with ALN-RSV01 delivered via inhalation at the 18th Annual Drug Delivery to the Lungs meeting being held in Edinburgh, U.K. These data represent an important milestone in the company’s efforts to advance ALN-RSV01 as an [...]

A study led by Massachusetts General Hospital (MGH) researchers may have found a key mechanism underlying idiopathic pulmonary fibrosis (IPF), a usually fatal lung disease for which transplantation is the only successful treatment. The investigators found that a specific molecular pathway appears responsible for key aspects of the scarring of lung tissue that characterizes IPF, [...]

Parents’ cultural beliefs influence how they view their children’s asthma and its treatment, according to a U.K. study published in the Archives of Disease in Childhood, Reuters Health reports. The study looked at a survey of the parents of 150 children treated at asthma clinics in London. Of the survey population, 41 parents had a [...]

Doctors have been given the green light to prescribe a life-saving jab that can treat severe allergic asthma. Professor Mark Britton, a Visiting Professor at the University of Surrey and Vice-Chair of the Postgraduate Medical School Advisory Council, was involved in the British trials of Xolair (Omalizumab) before it was licensed this year.
Xolair, which blocks [...]